San Diego-dependent Viking Therapeutics marked itself as a serious competitor inside the weight loss drug marketplace in February right after revealing promising data from the mid-phase demo of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when presented as a weekly injection As well as in March th